Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Clin Pharmacol Ther. 2013 Jul 26;94(5):570–573. doi: 10.1038/clpt.2013.153

Table 1.

Profiled metabolites that are altered upon aspirin exposure

Pathway Metabolite
Aspirin and xenobiotic metabolism ↑ 2,183% Salicylic acida ↑ 7% Glucuronic acida ↓ 7% 2-Hydroxybutanoic acida
↑ 160% 2-Hydroxyhippuric acida ↑ 26% Benzylalcohola
Purine pathway ↑ 77% Inosinea ↓ 5% Hypoxanthinea
↑ 8% Guanosinea ↓ 9% Xanthinea
Fatty acids ↓ 28% Oleic acida ↓ 20% Azelaic acida ↓ 15% Lauric acida
↓ 31% Palmitoleic acida ↑ 11% Threonic acida ↓ 32% Elaidic acida
↓ 15% Myristic acida ↓ 9% Isolinoleic acida ↓ 14% Capric acida
↓ 19% Linoleic acida ↓ 10% Palmitic acida ↓ 9% Methylhexadecanoic acida
Glycerol metabolism ↓ 14% 1-Monooleina ↓ 13% Glycerola ↑ 14% Glycerol-3-galactosidea
Amino acids and related metabolites ↓ 40% Glycylglycinec ↓ 9% Phenylalanineb ↓ 5% γ-Aminobutyric acidc
↓ 24% L-Aspartic acidb ↓ 9% Ethanolaminec ↓ 5% Serineb
↑ 19% O-phosphoethanolaminec ↑ 8% Indole-3-acetatea ↓ 5% Ornithinec
↑ 16% Methioninea ↑ 7% Serotoninc ↓ 4% L-Lysinec
↑ 12% Phenylacetic acida ↓ 6% Taurinec ↓ 2% L-Histidinec
↑ 11% Hydrocinnamic acida ↓ 6% Leucineb
↓ 10% L-Glutamic acidb ↓ 5% L-Valineb
Carbohydrates and carbohydrate conjugates ↑ 5% Glucosea ↑ 7% Threitola ↓ 10% Xylulosea
↓ 13% 3-Hydroxybutanoic acida
Other ↑ 7% Conduritol-β-epoxidea ↑ 9% Maleimidea

↑ = Metabolite increased after aspirin exposure; ↓ = metabolite decreased after aspirin exposure. Median percentage change in metabolite levels is provided. For metabolites measured by both GC-MS and LC-MS, percentage change from LC-MS is provided.

GC-MS, gas chromatography-mass spectrometry; LC-MS, liquid chromatography-mass spectrometry.

a

Measured by GC-MS.

b

Measured by GC-MS and LC-MS.

c

Measured by LC-MS